XTalks

JUNE 8, 2022

In a press release , the company says the goal of the Act4Biosimilars campaign is to help “address global health inequity and inequality” by increasing access to advanced medicines like biosimilars. On average, biosimilars are about 30 percent cheaper than original branded biologics, with expectations that they could become even cheaper. “As

Generic Pharmaceutical 69

Generic Pharmaceutical Production Medicine Branding 69

The Pharma Data

MARCH 15, 2022

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. director of the Office of Generic Drugs in the FDA Center for Drug Evaluation and Research. Today, the U.S.

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

The Pharma Data

MAY 15, 2023

Shamiram holds an AB from Smith College and Doctor of Medicine as well as a Master of Public Health, both from Emory University, U.S.A. She held other digital and data sciences related roles of increasing responsibility over her 27 years of a successful career with Lilly, including a Global Brand Development Leader role between 2013-2016.

Sales 40

Sales Production Doctors Doctor 40